Simon Paul Poidevin, born on October 31, 1958, is a retired Australian rugby union player renowned for his illustrious career. Notably, he played a pivotal role in the Wallabies' historic achievements, including the 1980 Bledisloe Cup victory against New Zealand, the 1984 "grand slam" tour of Britain and Ireland, and the 1991 Rugby World Cup triumph. Poidevin, a distinguished captain, stands among a select group of four Australian rugby icons to have secured rugby union's Grand Slam, claimed a series win in New Zealand, and earned a Rugby World Cup title.
Copyright 2023 – Finance News Network
10 Mar 2020 - Opthea Limited (ASX:OPT) Managing Director and CEO, Dr Megan Baldwin talks about results from the company's lead drug candidate OPT-302, and new funding for further clinical development for wet AMD (age-related macular degeneration) and DME (diabetic macular degeneration).
11 May 2023 - Sayona Mining Limited (ASX:SYA) Finance Manager Dougal Elder provides an update on the company, discussing commercial production, the offtake agreement with Piedmont, the PFS for the lithium carbonate refinery, the upgrade of the Moblan resource, and the timeline for lithium hydroxide production.
17 Dec 2019 - Aus Tin Mining Limited (ASX:ANW) CEO, Peter Williams discusses the funding package and resumption plan for the Granville Tin Project and plans for Granville to be a foundation asset in a proposed IPO.
21 Jun 2023 - Sayona Mining Limited (ASX:SYA) Finance Manager Dougal Elder discusses key takeaways from the recent lithium carbonate study, improvement in operation total value, and steps to get to first production in 2026.
29 Mar 2021 - Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer Dr David Cade talks about the company's clinical programs, including approvals, partnerships and significant value events anticipated in 2021.
03 Feb 2020 - Embark Ventures Managing Partner Michael Curtis provides an update on talks about the company's role as investment manager for MMJ Group Holdings (ASX:MMJ), the Canadian cannabis market and what’s planned for the portfolio.
13 Feb 2020 - Centuria Capital Group (ASX:CNI) Joint CEO, John McBain talks 1H20 results & outlook, including the contribution from recent acquisitions as group AUM now exceeds $7.3B.
27 Jun 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses promising results in the company's lead therapy for glioblastoma, and the timeline for the recently launched Phase 1b trial.
21 Mar 2021 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its proposed acquisition of CannaCare Health GmbH (CannaCare) one of Germany’s leading CBD (Cannabidiol) brands following the down scheduling of CBD in Europe late last year in what the Company sees as highly strategic opportunity and important pathway to profitability.
